Working...
ClinicalTrials.gov

Key Record Dates

ClinicalTrials.gov Identifier: NCT03371017
Brief Title: A Study of the Efficacy and Safety of Atezolizumab Plus Chemotherapy for Patients With Early Relapsing Recurrent Triple-Negative Breast Cancer (IMpassion132)

First Submitted : November 21, 2017
First Submitted that Met QC Criteria : December 7, 2017
First Posted : December 13, 2017

Last Update Submitted that Met QC Criteria : March 11, 2019
Last Update Posted : March 13, 2019